As adjuvant treatment in patients with operable breast cancer with or without lymph node involvement.
Non-small cell lung cancer.
Prostate cancer.
Gastric adenocarcinoma.
Head and neck cancer.
Docetaxel
Injectable solution for intravenous use
Box with 1 vial of concentrate and 1 vial of solvent
Each vial contains:
Anhydrous docetaxel 20.0 mg
Each solvent vial contains:
Absolute alcohol 191.1 mg
PF-46827
F018317052018
HN-M-0618-0252
202019
